MapLight Therapeutics (NASDAQ: MPLT) files notice for 36,284-share sale

Rhea-AI Filing Summary

Anatol Kreitzer filed a notice covering a planned sale of 36,284 shares of MapLight voting common stock of MapLight Therapeutics, Inc., to be sold through Morgan Stanley Smith Barney LLC on or about July 15, 2026 on Nasdaq, with an aggregate market value of $1,375,526.00.

The notice also lists prior sales of MapLight voting common stock in the past three months: 3,316 shares for $88,239.00 on April 15, 2026, and 45,422 shares for $1,347,066.00 on April 27, 2026. Shares outstanding are reported as 42,618,165.

Key Figures

Planned shares to be sold: 36,284 shares Aggregate market value of planned sale: $1,375,526.00 Shares outstanding: 42,618,165 shares +3 more

6 metrics

Planned shares to be sold 36,284 shares MapLight voting common stock to be sold through Morgan Stanley Smith Barney LLC

Aggregate market value of planned sale $1,375,526.00 Value associated with 36,284 MapLight voting common shares

Shares outstanding 42,618,165 shares Outstanding MapLight voting common stock as referenced in the sale notice

Approximate sale date 07/15/2026 Target date for sale of 36,284 MapLight voting common shares on Nasdaq

Shares sold on 04/15/2026 3,316 shares for $88,239.00 MapLight voting common stock sold by Anatol Kreitzer in prior 3 months

Shares sold on 04/27/2026 45,422 shares for $1,347,066.00 MapLight voting common stock sold by Anatol Kreitzer in prior 3 months

Key Terms

voting common stock, Restricted stock unit settlement, Securities Sold During The Past 3 Months, Nasdaq

4 terms

voting common stock financial

"MapLight voting common stock | Morgan Stanley Smith Barney LLC"

Restricted stock unit settlement financial

"07/15/2026 | Restricted stock unit settlement | MapLight Therapeutics"

Securities Sold During The Past 3 Months regulatory

"144/A: Securities Sold During The Past 3 Months"

Nasdaq financial

"07/15/2026 | Nasdaq"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/15/2026 - 09:24 PM Accepted by SEC EDGAR 07/15/2026 - 09:23 PM Learn about SEC filing dates

FAQ

What does MapLight Therapeutics (MPLT) disclose in this 144/A filing?

The filing discloses a planned sale of 36,284 shares of MapLight voting common stock of MapLight Therapeutics, Inc., with an aggregate market value of $1,375,526.00, and details stock sales made during the prior three months.

How many MPLT shares are proposed for sale and through which broker?

The notice covers a proposed sale of 36,284 shares of MapLight voting common stock to be executed through Morgan Stanley Smith Barney LLC at 1 New York Plaza, 8th Floor, New York, NY 10004, using Nasdaq as the trading market.

What valuation and share count context does MapLight (MPLT) provide?

The proposed sale of 36,284 MapLight voting common shares has an aggregate market value of $1,375,526.00. The filing also reports that there are 42,618,165 shares of the same class outstanding, providing context for the size of the planned sale.

What prior MPLT stock sales by Anatol Kreitzer are listed in the last three months?

Anatol Kreitzer is shown selling MapLight voting common stock twice: 3,316 shares for $88,239.00 on April 15, 2026, and 45,422 shares for $1,347,066.00 on April 27, 2026, both within the three-month lookback period.

When is the planned sale of MPLT shares and on which market will it occur?

The approximate sale date for the 36,284 shares of MapLight voting common stock is July 15, 2026. The securities are listed for trading on Nasdaq, which is identified as the securities exchange for the planned transaction.

What is the nature of the MPLT shares being sold in this 144/A filing?

The securities are described as MapLight voting common stock, and the sale is linked to a restricted stock unit settlement. The issuer is identified as MapLight Therapeutics, Inc., with trading to occur on Nasdaq around July 15, 2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK
Filer CCC
Previous Accession Number Of The Filing
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
MapLight voting common stock	Morgan Stanley Smith Barney LLC 1 New York Plaza 8th Floor New York NY 10004	36284	1375526.00	42618165	07/15/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
MapLight voting common stock	07/15/2026	Restricted stock unit settlement	MapLight Therapeutics, Inc.			36284	07/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Anatol Kreitzer 800 Chesapeake Drive Redwood City CA 94063	MapLight voting common stock	04/15/2026	3316	88239.00
Anatol Kreitzer 800 Chesapeake Drive Redwood City CA 94063	MapLight voting common stock	04/27/2026	45422	1347066.00

144/A: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)